Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged Mice
Accumulating evidence indicates that the increased burden of senescent cells (SCs) in aged organisms plays an important role in many age-associated diseases. The pharmacological elimination of SCs with “senolytics” has been emerging as a new therapy for age-related diseases and extending the healthy...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-03-01
|
| Series: | International Journal of Molecular Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1422-0067/24/7/6554 |
| _version_ | 1797607758939291648 |
|---|---|
| author | Yanghuan Zhang Dongxiao Gao Yang Yuan Runzi Zheng Manting Sun Shuting Jia Jing Liu |
| author_facet | Yanghuan Zhang Dongxiao Gao Yang Yuan Runzi Zheng Manting Sun Shuting Jia Jing Liu |
| author_sort | Yanghuan Zhang |
| collection | DOAJ |
| description | Accumulating evidence indicates that the increased burden of senescent cells (SCs) in aged organisms plays an important role in many age-associated diseases. The pharmacological elimination of SCs with “senolytics” has been emerging as a new therapy for age-related diseases and extending the healthy lifespan. In the present study, we identified that cycloastragenol (CAG), a secondary metabolite isolated from <i>Astragalus membrananceus</i>, delays age-related symptoms in mice through its senolytic activity against SCs. By screening a series of compounds, we found that CAG selectively kills SCs by inducing SCs apoptosis and that this process is associated with the inhibition of Bcl-2 antiapoptotic family proteins and the PI3K/AKT/mTOR pathway. In addition, CAG treatment also suppressed the development of the senescence-associated secretory phenotype (SASP) in SCs, thereby inhibiting cell migration mediated by the SASP. Furthermore, the administration of CAG for 2 weeks to mice with irradiation-induced aging alleviated the burden of SCs and improved the animals’ age-related physical dysfunction. Overall, our studies demonstrate that CAG is a novel senolytic agent with in vivo activity that has the potential to be used in the treatment of age-related diseases. |
| first_indexed | 2024-03-11T05:35:10Z |
| format | Article |
| id | doaj.art-b33bfd83d4ee464f9a7c5b025d7bd7b4 |
| institution | Directory Open Access Journal |
| issn | 1661-6596 1422-0067 |
| language | English |
| last_indexed | 2024-03-11T05:35:10Z |
| publishDate | 2023-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | International Journal of Molecular Sciences |
| spelling | doaj.art-b33bfd83d4ee464f9a7c5b025d7bd7b42023-11-17T16:52:47ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-03-01247655410.3390/ijms24076554Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged MiceYanghuan Zhang0Dongxiao Gao1Yang Yuan2Runzi Zheng3Manting Sun4Shuting Jia5Jing Liu6Laboratory of Molecular Genetics of Aging and Tumor, Medical School, Kunming University of Science and Technology, Kunming 650500, ChinaLaboratory of Molecular Genetics of Aging and Tumor, Medical School, Kunming University of Science and Technology, Kunming 650500, ChinaLaboratory of Molecular Genetics of Aging and Tumor, Medical School, Kunming University of Science and Technology, Kunming 650500, ChinaLaboratory of Molecular Genetics of Aging and Tumor, Medical School, Kunming University of Science and Technology, Kunming 650500, ChinaLaboratory of Molecular Genetics of Aging and Tumor, Medical School, Kunming University of Science and Technology, Kunming 650500, ChinaLaboratory of Molecular Genetics of Aging and Tumor, Medical School, Kunming University of Science and Technology, Kunming 650500, ChinaLaboratory of Molecular Genetics of Aging and Tumor, Medical School, Kunming University of Science and Technology, Kunming 650500, ChinaAccumulating evidence indicates that the increased burden of senescent cells (SCs) in aged organisms plays an important role in many age-associated diseases. The pharmacological elimination of SCs with “senolytics” has been emerging as a new therapy for age-related diseases and extending the healthy lifespan. In the present study, we identified that cycloastragenol (CAG), a secondary metabolite isolated from <i>Astragalus membrananceus</i>, delays age-related symptoms in mice through its senolytic activity against SCs. By screening a series of compounds, we found that CAG selectively kills SCs by inducing SCs apoptosis and that this process is associated with the inhibition of Bcl-2 antiapoptotic family proteins and the PI3K/AKT/mTOR pathway. In addition, CAG treatment also suppressed the development of the senescence-associated secretory phenotype (SASP) in SCs, thereby inhibiting cell migration mediated by the SASP. Furthermore, the administration of CAG for 2 weeks to mice with irradiation-induced aging alleviated the burden of SCs and improved the animals’ age-related physical dysfunction. Overall, our studies demonstrate that CAG is a novel senolytic agent with in vivo activity that has the potential to be used in the treatment of age-related diseases.https://www.mdpi.com/1422-0067/24/7/6554CAGsenolyticcell senescenceaging |
| spellingShingle | Yanghuan Zhang Dongxiao Gao Yang Yuan Runzi Zheng Manting Sun Shuting Jia Jing Liu Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged Mice International Journal of Molecular Sciences CAG senolytic cell senescence aging |
| title | Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged Mice |
| title_full | Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged Mice |
| title_fullStr | Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged Mice |
| title_full_unstemmed | Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged Mice |
| title_short | Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged Mice |
| title_sort | cycloastragenol a novel senolytic agent that induces senescent cell apoptosis and restores physical function in tbi aged mice |
| topic | CAG senolytic cell senescence aging |
| url | https://www.mdpi.com/1422-0067/24/7/6554 |
| work_keys_str_mv | AT yanghuanzhang cycloastragenolanovelsenolyticagentthatinducessenescentcellapoptosisandrestoresphysicalfunctionintbiagedmice AT dongxiaogao cycloastragenolanovelsenolyticagentthatinducessenescentcellapoptosisandrestoresphysicalfunctionintbiagedmice AT yangyuan cycloastragenolanovelsenolyticagentthatinducessenescentcellapoptosisandrestoresphysicalfunctionintbiagedmice AT runzizheng cycloastragenolanovelsenolyticagentthatinducessenescentcellapoptosisandrestoresphysicalfunctionintbiagedmice AT mantingsun cycloastragenolanovelsenolyticagentthatinducessenescentcellapoptosisandrestoresphysicalfunctionintbiagedmice AT shutingjia cycloastragenolanovelsenolyticagentthatinducessenescentcellapoptosisandrestoresphysicalfunctionintbiagedmice AT jingliu cycloastragenolanovelsenolyticagentthatinducessenescentcellapoptosisandrestoresphysicalfunctionintbiagedmice |